EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparative analysis of lipid-lowering mechanisms in efficacy-divergent traditional Chinese medicines

Xiao-Le Wang, Jia-Yun Li, Yu-Han Guo, Guo-Hao Zhai, Ni-Yuan Fang, Miao-Miao Peng, Neng-Yu Chen, Bing Qin, Qian-Qian Chen, E-Hu Liu

Phytomedicine · 2026-07 · 157 · 158295

DOI: 10.1016/j.phymed.2026.158295 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Phytomedicine, 2026-07. Verfasst von Xiao-Le Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Hauptthemen laut MEDLINE: Hypolipidemic Agents, Hyperlipidemias, Drugs, Chinese Herbal. Die Arbeit nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Traditional Chinese medicines (TCMs) demonstrate efficacy in hyperlipidemia prevention and treatment, irrespective of their traditional classifications. However, the molecular mechanisms underlying their hypolipidemic activities remain incompletely defined. This study investigates the lipid-lowering effects and associated mechanisms of three clinically applied TCMs: Citrus reticulata Blanco (Citri Reticulatae Pericarpium, CRP), Nelumbo nucifera Gaertn. (Nelumbinis Folium, NF), Alisma orientale (Sam.) Juzep. (Alismatis Rhizoma, AR). PURPOSE To compare the molecular mechanisms underpinning the hypolipidemic activities of these three different TCMs. METHODS Hypolipidemic effects were assessed using palmitic acid (PA) and oleic acid (OA)-stimulated HepG2 cells in vitro and a high-fat diet (HFD)-induced hyperlipidemic mouse model in vivo. Aqueous extracts and hydroalcoholic extracts of each TCM were evaluated. Label-free proteome analysis was used to identify differentially expressed proteins (DEPs) related to lipid metabolism in the hyperlipidemic model. DEPs functions were validated via cellular thermal shift assay, overexpression/knockdown experiments, total cholesterol (TC) and triglyceride (TG) analysis. RESULTS Hydroalcoholic extracts exhibited superior lipid-lowering efficacy compared to aqueous extracts. Proteomic analysis revealed 270 DEPs. Specific targets associated with each TCM's activity were identified: acyl-CoA dehydrogenase, mitochondrial (ACADSB) for CRP; liver carboxylesterase 1 (CES1) for NF; bile acid-CoA: amino acid N-acyltransferase (BAAT) for AR. Shared targets across all three TCMs included glutathione S-transferase Mu 3 (GSTM3), phosphoenolpyruvate carboxykinase, cytosolic [GTP] (PCK1), ornithine aminotransferase, mitochondrial (OAT), and retinol-binding protein 4 (RBP4). CONCLUSION CRP, NF, and AR exert hypolipidemic effects through distinct targets (ACADSB, CES1, BAAT, respectively) and shared targets (OAT, GSTM3, PCK1, RBP4), revealing a multi-target regulatory paradigm for TCMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypolipidemic AgentsHyperlipidemiasDrugs, Chinese HerbalAnimalsHumansMaleHep G2 CellsMiceLipid MetabolismDiet, High-FatMedicine, Chinese TraditionalMice, Inbred C57BLPalmitic AcidAlismaTriglycerides

Stichwörter der Autor:innen

Alismatis Rhizoma (AR)Citri Reticulatae Pericarpium (CRP)HyperlipidemiaHypolipidemic mechanismsLabel-free proteomeNelumbinis Folium (NF)Traditional Chinese medicines (TCMs)

Substanzen

Hypolipidemic AgentsDrugs, Chinese HerbalPalmitic AcidTriglycerides

Autor:innen und Institutionen

  • School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • College of Traditional Chinese Medicine and Food Engineering, Shanxi University of Chinese Medicine, Taiyuan, Shanxi, 030619, China.
  • School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address: qinbing@njucm.edu.cn.
  • School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address: 300572@njucm.edu.cn.
  • School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address: liuehu2011@163.com.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Wang, X. L., Li, J. Y., Guo, Y. H., Zhai, G. H., Fang, N. Y., Peng, M. M., Chen, N. Y., Qin, B., Chen, Q. Q., & Liu, E. H. (2026). Comparative analysis of lipid-lowering mechanisms in efficacy-divergent traditional Chinese medicines. Phytomedicine, 157, 158295. https://doi.org/10.1016/j.phymed.2026.158295

Vancouver

Wang XL, Li JY, Guo YH, Zhai GH, Fang NY, Peng MM, et al. Comparative analysis of lipid-lowering mechanisms in efficacy-divergent traditional Chinese medicines. Phytomedicine. 2026;157:158295. doi:10.1016/j.phymed.2026.158295

BibTeX
@article{Wang2026,
  author = {Wang, Xiao-Le and Li, Jia-Yun and Guo, Yu-Han and Zhai, Guo-Hao and Fang, Ni-Yuan and Peng, Miao-Miao and Chen, Neng-Yu and Qin, Bing and Chen, Qian-Qian and Liu, E-Hu},
  title = {Comparative analysis of lipid-lowering mechanisms in efficacy-divergent traditional Chinese medicines},
  journal = {Phytomedicine},
  year = {2026},
  volume = {157},
  pages = {158295},
  doi = {10.1016/j.phymed.2026.158295}
}
Kostenlos starten →